397.70999 USD
0.367
0.09%
Last update Dec 16, 3:33 PM GMT
Main market
Day range
390.67990
397.70999
Previous close
397.34299
Open
390.67990
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
397.71
0.37
0.09%

Financials

Income statement

Fundamentals currency is IDR
Fiscal date Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total reported revenue 1.7T 1.4T 1.3T 1.9T
Cost of revenue 797.8B 704.9B 629.0B 887.6B
Gross profit 946.5B 738.8B 678.2B 1.0T
Operating expense
Research & development
Selling general and admin 77.1B 67.0B 47.0B 88.4B
Other operating expenses 7.6B 7.1B 3.4B -10.2B
Operating income 799.8B 577.1B 566.0B 897.9B
Non operating interest income
Income 44.4B 41.2B 34.9B 38.2B
Expense 87.7B 76.2B 79.5B 78.8B
Other income expense
Pretax income 524.3B 451.7B 407.5B 751.6B
Tax provision 1.4B 1.2B -1.5B 1.1B
Net income 522.9B 450.5B 409.0B 750.4B
Basic EPS 7.7
Diluted EPS 7.7
Basic average shares 48.2B
Diluted average shares 48.2B
EBITDA 645.9B 529.4B 518.3B 855.9B
Net income from continuing op.
Minority interests -85.0B -67.6B -38.4B -89.9B
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours

11:29
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).